MNOV Competitors & Alternatives

Compare MediciNova Inc with similar stocks in the same industry

Biotechnology

MNOV

Main Stock
$1.31
+3.15%
Tradestie Score
50
Market Cap
$61.31M
Revenue Growth
12.4%
Analyst Upside
+529.8%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: Small molecule therapeutics, Neuroinflammation modulation
Major Customers 3
Neurology clinics Hospitals Research institutions
Critical Suppliers 2
Contract research organizations API manufacturers
Direct Ecosystem Rivals 3

Top Competitors

215 stocks in Biotechnology
Company Price Market Cap P/E Score Action
ACHV Achieve Life Sciences, Inc.
$6.78
+0.89%
$158.43M - 56 Compare
NVCT Nuvectis Pharma, Inc. Common Stock
$19.39
-2.27%
$154.27M - 38 Compare
OBIO Orchestra BioMed Holdings, Inc. Ordinary Shares
$6.58
-6.00%
$137.59M - 36 Compare
CLYM Climb Bio, Inc. Common Stock
$9.19
-0.97%
$133.50M - 42 Compare
SRZN Surrozen, Inc. Common
$28.46
-7.21%
$117.07M - 34 Compare
ANRO Alto Neuroscience Inc.
$25.37
-4.30%
$110.20M - 44 Compare
LITS Lite Strategy, Inc. Common Stock
$0.80
-4.03%
$91.28M - 57 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.31
+0.76%
$84.52M - 40 Compare
IMMX Immix Biopharma, Inc. Common Stock
$6.96
-1.14%
$67.94M - 48 Compare
NERV Minerva Neurosciences, Inc
$2.00
-5.66%
$14.69M - 41 Compare

Data updated: Nov 22, 2026 | Industry: Biotechnology (SIC 2834)

215 stocks in this industry